CoronaVac is a novel coronavirus vaccine developed by Beijing Kexing Zhongwei Biotechnology Co., Ltd..

On February 5th, 20021,the State Administration of Pharmaceutical Products approved the conditional listing of inactivated vaccine Kelaifu from novel coronavirus in China. On June 1, the World Health Organization announced that Clive had officially passed the WHO emergency use certification. 165438+ 10/6, Enrique Domingo, director of the US Food and Drug Administration in the Philippines, announced that COVID-19 vaccine produced by China Kexing Company had been approved for vaccination in the Philippines. On March 12, the US Food and Drug Administration approved China Kexing vaccine for children over 6 years old to receive COVID-19 vaccine.